{"id":43876,"date":"2025-10-20T19:27:31","date_gmt":"2025-10-20T11:27:31","guid":{"rendered":"https:\/\/flcube.com\/?p=43876"},"modified":"2025-10-20T19:27:32","modified_gmt":"2025-10-20T11:27:32","slug":"wuhan-healthgen-announces-star-market-ipo-of-oryzogen-shares","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=43876","title":{"rendered":"Wuhan Healthgen Announces STAR Market IPO of ORYZOGEN Shares"},"content":{"rendered":"\n<p><strong>Wuhan Healthgen Biotechnology Corp.<\/strong> (SHA: 688765) today announced that the <strong>Shanghai Stock Exchange<\/strong> has approved its application to sell <strong>RMB ordinary shares (A\u2011shares)<\/strong> on the <strong>Science and Technology Innovation Board (STAR Market)<\/strong>. The company will issue <strong>89,451,354 new shares<\/strong> at a final offering price of <strong>RMB\u202f29.06 per share<\/strong>, raising approximately <strong>RMB\u202f2.6\u202fbillion<\/strong> in capital.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-key-facts\">Key Facts<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Issuer<\/strong><\/td><td>Wuhan Healthgen Biotechnology Corp.<\/td><\/tr><tr><td><strong>Ticker<\/strong><\/td><td>ORYZOGEN (688765)<\/td><\/tr><tr><td><strong>Exchange<\/strong><\/td><td>Shanghai Stock Exchange \u2013 STAR Market<\/td><\/tr><tr><td><strong>Offering Size<\/strong><\/td><td>89,451,354 shares<\/td><\/tr><tr><td><strong>Price per Share<\/strong><\/td><td>RMB\u202f29.06<\/td><\/tr><tr><td><strong>Capital Raised<\/strong><\/td><td>\u2248\u202fRMB\u202f2.6\u202fbillion<\/td><\/tr><tr><td><strong>Share Type<\/strong><\/td><td>New issue (no transfer of existing shares)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-implications\">Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Capital Deployment<\/strong> \u2013 The proceeds will underpin Wuhan Healthgen\u2019s R&amp;D pipeline, accelerate clinical development of its biotech platform, and support strategic acquisitions.<\/li>\n\n\n\n<li><strong>Market Positioning<\/strong> \u2013 Listing on the STAR Market, a high\u2011growth venue for science\u2011driven companies, enhances visibility among institutional investors and positions ORYZOGEN for future growth.<\/li>\n\n\n\n<li><strong>Investor Outlook<\/strong> \u2013 The IPO\u2019s strong pricing and sizeable capital raise signal robust demand for high\u2011tech biotech exposure in China\u2019s evolving capital markets.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-forward-looking-statements\">Forward\u2011Looking Statements<\/h3>\n\n\n\n<p>This release contains forward\u2011looking statements that involve risks and uncertainties. Actual results may differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/688765_20251020_IKE7.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 688765_20251020_IKE7.\"><\/object><a id=\"wp-block-file--media-0a8f37da-e1f7-411e-bf66-3b2c33680a7f\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/688765_20251020_IKE7.pdf\">688765_20251020_IKE7<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/688765_20251020_IKE7.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-0a8f37da-e1f7-411e-bf66-3b2c33680a7f\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Wuhan Healthgen Biotechnology Corp. (SHA: 688765) today announced that the Shanghai Stock Exchange has approved&#8230;<\/p>\n","protected":false},"author":1,"featured_media":43877,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[2512,72,4405],"class_list":["post-43876","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-healthgen-biotechnology","tag-ipo","tag-sha-688765"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Wuhan Healthgen Announces STAR Market IPO of ORYZOGEN Shares - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Wuhan Healthgen Biotechnology Corp. (SHA: 688765) today announced that the Shanghai Stock Exchange has approved its application to sell RMB ordinary shares (A\u2011shares) on the Science and Technology Innovation Board (STAR Market). The company will issue 89,451,354 new shares at a final offering price of RMB\u202f29.06 per share, raising approximately RMB\u202f2.6\u202fbillion in capital.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=43876\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Wuhan Healthgen Announces STAR Market IPO of ORYZOGEN Shares\" \/>\n<meta property=\"og:description\" content=\"Wuhan Healthgen Biotechnology Corp. (SHA: 688765) today announced that the Shanghai Stock Exchange has approved its application to sell RMB ordinary shares (A\u2011shares) on the Science and Technology Innovation Board (STAR Market). The company will issue 89,451,354 new shares at a final offering price of RMB\u202f29.06 per share, raising approximately RMB\u202f2.6\u202fbillion in capital.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=43876\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-20T11:27:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-20T11:27:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2008.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43876#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43876\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Wuhan Healthgen Announces STAR Market IPO of ORYZOGEN Shares\",\"datePublished\":\"2025-10-20T11:27:31+00:00\",\"dateModified\":\"2025-10-20T11:27:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43876\"},\"wordCount\":201,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43876#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2008.webp\",\"keywords\":[\"Healthgen Biotechnology\",\"IPO\",\"SHA: 688765\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43876#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43876\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=43876\",\"name\":\"Wuhan Healthgen Announces STAR Market IPO of ORYZOGEN Shares - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43876#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43876#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2008.webp\",\"datePublished\":\"2025-10-20T11:27:31+00:00\",\"dateModified\":\"2025-10-20T11:27:32+00:00\",\"description\":\"Wuhan Healthgen Biotechnology Corp. (SHA: 688765) today announced that the Shanghai Stock Exchange has approved its application to sell RMB ordinary shares (A\u2011shares) on the Science and Technology Innovation Board (STAR Market). The company will issue 89,451,354 new shares at a final offering price of RMB\u202f29.06 per share, raising approximately RMB\u202f2.6\u202fbillion in capital.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43876#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=43876\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43876#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2008.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/2008.webp\",\"width\":1080,\"height\":608,\"caption\":\"Wuhan Healthgen Announces STAR Market IPO of ORYZOGEN Shares\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=43876#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wuhan Healthgen Announces STAR Market IPO of ORYZOGEN Shares\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Wuhan Healthgen Announces STAR Market IPO of ORYZOGEN Shares - Insight, China&#039;s Pharmaceutical Industry","description":"Wuhan Healthgen Biotechnology Corp. (SHA: 688765) today announced that the Shanghai Stock Exchange has approved its application to sell RMB ordinary shares (A\u2011shares) on the Science and Technology Innovation Board (STAR Market). The company will issue 89,451,354 new shares at a final offering price of RMB\u202f29.06 per share, raising approximately RMB\u202f2.6\u202fbillion in capital.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=43876","og_locale":"en_US","og_type":"article","og_title":"Wuhan Healthgen Announces STAR Market IPO of ORYZOGEN Shares","og_description":"Wuhan Healthgen Biotechnology Corp. (SHA: 688765) today announced that the Shanghai Stock Exchange has approved its application to sell RMB ordinary shares (A\u2011shares) on the Science and Technology Innovation Board (STAR Market). The company will issue 89,451,354 new shares at a final offering price of RMB\u202f29.06 per share, raising approximately RMB\u202f2.6\u202fbillion in capital.","og_url":"https:\/\/flcube.com\/?p=43876","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-20T11:27:31+00:00","article_modified_time":"2025-10-20T11:27:32+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2008.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=43876#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=43876"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Wuhan Healthgen Announces STAR Market IPO of ORYZOGEN Shares","datePublished":"2025-10-20T11:27:31+00:00","dateModified":"2025-10-20T11:27:32+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=43876"},"wordCount":201,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=43876#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2008.webp","keywords":["Healthgen Biotechnology","IPO","SHA: 688765"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=43876#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=43876","url":"https:\/\/flcube.com\/?p=43876","name":"Wuhan Healthgen Announces STAR Market IPO of ORYZOGEN Shares - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=43876#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=43876#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2008.webp","datePublished":"2025-10-20T11:27:31+00:00","dateModified":"2025-10-20T11:27:32+00:00","description":"Wuhan Healthgen Biotechnology Corp. (SHA: 688765) today announced that the Shanghai Stock Exchange has approved its application to sell RMB ordinary shares (A\u2011shares) on the Science and Technology Innovation Board (STAR Market). The company will issue 89,451,354 new shares at a final offering price of RMB\u202f29.06 per share, raising approximately RMB\u202f2.6\u202fbillion in capital.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=43876#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=43876"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=43876#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2008.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2008.webp","width":1080,"height":608,"caption":"Wuhan Healthgen Announces STAR Market IPO of ORYZOGEN Shares"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=43876#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Wuhan Healthgen Announces STAR Market IPO of ORYZOGEN Shares"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/2008.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=43876"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43876\/revisions"}],"predecessor-version":[{"id":43879,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/43876\/revisions\/43879"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/43877"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=43876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=43876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=43876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}